ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ESTABLISHMENT LABS HOLDINGS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$58.26−0.92 (-1.55%)
Close on Oct 19, 2026
- Market cap
- $1.75B
- P/E (TTM)
- –
- Dividend yield
- –
ESTABLISHMENT LABS HOLDINGS INC. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OUS | $42.85M | $40.28M | – | – | $41.05M | $35.28M | – | – | – | – | – | – | 63.4% | +4.4% |
| United States | $24.69M | $19.59M | – | – | $10.25M | $6.10M | – | – | – | – | – | – | 36.6% | +140.9% |
| Latin America | – | – | $11.66M | $11.65M | $9.49M | $7.13M | $7.93M | $9.57M | $8.89M | $7.91M | $8.37M | $12.58M | – | – |
| Other | – | – | – | – | – | – | – | – | $125.00K | $62.00K | $547.00K | $180.00K | – | – |
| Asia-Pacific | – | – | $9.10M | $11.10M | $7.58M | $6.76M | $15.59M | $10.77M | $14.14M | $8.60M | $5.99M | $2.42M | – | – |
| EMEA (Europe / Middle East / Africa) | – | – | $26.52M | $19.16M | $23.98M | $21.39M | $17.09M | $19.56M | $20.96M | $20.60M | $16.65M | $23.33M | – | – |
| North America | – | – | $17.33M | $11.88M | $10.25M | $6.10M | $3.91M | $318.00K | $125.00K | $62.00K | $547.00K | $180.00K | – | – |
From the segment and revenue-disaggregation notes of Establishment Labs's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.